1
Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
Condition(s):Hemophilia ALast Updated:August 19, 2019Unknown status
Factor VIII: 814 Clinical Trials, Page 1 of 82
Hide Studies Not Open or Pending
2
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients
Condition(s):Hemophilia ALast Updated:May 3, 2021Completed
3
Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A
Condition(s):Severe Haemophilia ALast Updated:February 23, 2018Completed
4
A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
Condition(s):Severe Hemophilia ALast Updated:July 14, 2021Recruiting
5
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq
Condition(s):Hemophilia ALast Updated:February 23, 2021Terminated
6
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A
Condition(s):Hemophilia ALast Updated:October 26, 2021Recruiting
7
Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A
Condition(s):Hemophilia ALast Updated:October 31, 2014Unknown status
8
Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:November 4, 2014Unknown status
9
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
Condition(s):Hemophilia A; Factor VIIILast Updated:April 23, 2021Recruiting
10
Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:March 17, 2021Completed